IN2015DN01616A - - Google Patents

Download PDF

Info

Publication number
IN2015DN01616A
IN2015DN01616A IN1616DEN2015A IN2015DN01616A IN 2015DN01616 A IN2015DN01616 A IN 2015DN01616A IN 1616DEN2015 A IN1616DEN2015 A IN 1616DEN2015A IN 2015DN01616 A IN2015DN01616 A IN 2015DN01616A
Authority
IN
India
Prior art keywords
tissue
cells
cell formulation
myocardial
pluripotent stem
Prior art date
Application number
Other languages
English (en)
Inventor
Masanori Yoshida
Shinya Minatoguchi
Mari Dezawa
Original Assignee
Clio Inc
Univ Gifu
Univ Tohoku
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clio Inc, Univ Gifu, Univ Tohoku filed Critical Clio Inc
Publication of IN2015DN01616A publication Critical patent/IN2015DN01616A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0607—Non-embryonic pluripotent stem cells, e.g. MASC
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/03—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from non-embryonic pluripotent stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
IN1616DEN2015 2012-08-17 2013-08-15 IN2015DN01616A (enrdf_load_stackoverflow)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2012181029 2012-08-17
PCT/JP2013/054049 WO2014027474A1 (ja) 2012-08-17 2013-02-19 心筋梗塞の修復再生を誘導する多能性幹細胞
PCT/JP2013/071981 WO2014027684A1 (ja) 2012-08-17 2013-08-15 心筋梗塞の修復再生を誘導する多能性幹細胞

Publications (1)

Publication Number Publication Date
IN2015DN01616A true IN2015DN01616A (enrdf_load_stackoverflow) 2015-07-03

Family

ID=50685515

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1616DEN2015 IN2015DN01616A (enrdf_load_stackoverflow) 2012-08-17 2013-08-15

Country Status (14)

Country Link
US (3) US9844570B2 (enrdf_load_stackoverflow)
EP (2) EP2886123B1 (enrdf_load_stackoverflow)
JP (1) JP5968442B2 (enrdf_load_stackoverflow)
KR (1) KR101730052B1 (enrdf_load_stackoverflow)
CN (1) CN104582711B (enrdf_load_stackoverflow)
AU (1) AU2013303492B2 (enrdf_load_stackoverflow)
CA (1) CA2882239C (enrdf_load_stackoverflow)
DK (1) DK2886123T3 (enrdf_load_stackoverflow)
ES (1) ES2767182T3 (enrdf_load_stackoverflow)
IN (1) IN2015DN01616A (enrdf_load_stackoverflow)
PL (1) PL2886123T3 (enrdf_load_stackoverflow)
PT (1) PT2886123T (enrdf_load_stackoverflow)
SG (2) SG11201501185WA (enrdf_load_stackoverflow)
WO (2) WO2014027474A1 (enrdf_load_stackoverflow)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014027474A1 (ja) 2012-08-17 2014-02-20 株式会社Ｃｌｉｏ 心筋梗塞の修復再生を誘導する多能性幹細胞
JP2015160820A (ja) * 2014-02-26 2015-09-07 株式会社Ｃｌｉｏ 慢性腎障害治療のための多能性幹細胞
JP6452107B2 (ja) * 2014-09-05 2019-01-16 国立大学法人 東京大学 糖尿病性皮膚潰瘍治療のための多能性幹細胞
WO2016168993A1 (en) 2015-04-22 2016-10-27 Innolife Co., Ltd. Methods of tissue repair and regeneration
JP6770673B2 (ja) * 2016-02-26 2020-10-21 国立大学法人東海国立大学機構 急性心筋梗塞の予後マーカー及びその利用
EP3479833B1 (en) * 2016-07-01 2023-11-01 Tohoku University Prophylactic or therapeutic agent for organ fibrosis
WO2018021515A1 (ja) * 2016-07-29 2018-02-01 国立大学法人東北大学 血管障害の予防又は治療剤
CA3032925A1 (en) * 2016-08-03 2018-02-08 Life Science Institute, Inc. Alleviation and treatment of ischemia reperfusion-induced lung injury using pluripotent stem cells
WO2018025975A1 (ja) * 2016-08-03 2018-02-08 株式会社生命科学インスティテュート インビトロで多能性幹細胞を分化誘導する方法
JP7165352B2 (ja) * 2016-08-03 2022-11-04 国立大学法人東海国立大学機構 多能性幹細胞による慢性肺疾患の改善及び治療
CN106822899B (zh) * 2017-03-10 2020-11-27 北京大学 一种通过抑制自噬促进心肌再生的药物
JP7489016B2 (ja) * 2017-10-17 2024-05-23 国立大学法人東北大学 骨軟骨修復を誘導する多能性幹細胞
JP7102666B2 (ja) * 2018-01-25 2022-07-20 国立大学法人東海国立大学機構 Ｍｕｓｅ細胞動員剤及び心筋障害への利用
JP7072777B2 (ja) * 2018-07-03 2022-05-23 株式会社生命科学インスティテュート 慢性腎障害治療のための多能性幹細胞
CN110302212A (zh) * 2019-07-17 2019-10-08 陶正博 一种用于治疗急性心肌梗死的细胞制剂及其制备方法
JP7500083B2 (ja) 2019-08-19 2024-06-17 セルアクシア株式会社 細胞含有医薬組成物
JP7627496B2 (ja) * 2019-09-05 2025-02-06 国立大学法人東北大学 心筋炎の治療剤
WO2021085639A1 (ja) * 2019-10-31 2021-05-06 株式会社生命科学インスティテュート 多能性幹細胞による間質性膀胱炎の治療
WO2021201286A1 (ja) 2020-04-02 2021-10-07 国立大学法人東北大学 ハイポテンシャル多能性幹細胞
TWI825446B (zh) * 2020-08-14 2023-12-11 中國醫藥大學 醫藥組合物治療組織缺血狀況之用途
JP2021073305A (ja) * 2021-02-09 2021-05-13 株式会社生命科学インスティテュート 慢性腎障害治療のための多能性幹細胞
CN119198334A (zh) * 2024-10-31 2024-12-27 北京大学深圳研究生院 一种心肌梗死边界区组织鉴定方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4543193A (en) * 1992-06-22 1994-01-24 Henry E. Young Scar inhibitory factor and use thereof
DE69831957T3 (de) * 1997-07-14 2009-07-23 Osiris Therapeutics, Inc. Herzmuskelregenerierung unter verwendung mesenchymaler stammzellen
EP1100870B1 (en) * 1998-07-31 2008-01-02 Genzyme Corporation Improvement of cardiac function by mesenchymal stem cell transplantation
US20020061587A1 (en) 2000-07-31 2002-05-23 Piero Anversa Methods and compositions for the repair and/or regeneration of damaged myocardium
CA2434362A1 (en) * 2001-01-20 2002-07-25 Cardion Ag Pluripotent adult stem cells derived from regenerative tissue
IL159580A0 (en) 2001-07-12 2004-06-01 Geron Corp Cells of the cardiomyocyte lineage produced from human pluripotent stem cells
JP5103626B2 (ja) 2005-01-27 2012-12-19 財団法人ヒューマンサイエンス振興財団 間葉系幹細胞を含む細胞シート
ES2367525T3 (es) 2005-12-13 2011-11-04 Kyoto University Factor de reprogramación celular.
CN101517069A (zh) * 2006-07-13 2009-08-26 塞拉帝思股份公司 由人类胚泡来源的干细胞衍生的多能心脏前体细胞新种群
WO2009046058A1 (en) * 2007-10-01 2009-04-09 University Of Miami A method to amplify cardiac stem cells in vitro and in vivo
WO2009057537A1 (ja) 2007-11-02 2009-05-07 Jcr Pharmaceuticals Co., Ltd. ヒト間葉系幹細胞含有医薬組成物
JP5564679B2 (ja) 2009-04-16 2014-07-30 公益財団法人ヒューマンサイエンス振興財団 心筋細胞分化誘導促進剤およびその使用方法
US9550975B2 (en) * 2009-07-15 2017-01-24 Mari Dezawa SSEA-3 pluripotent stem cell isolated from body tissue
WO2012054501A1 (en) * 2010-10-18 2012-04-26 Sunshine Biotech Inc. Human multipotent embryonic stem cell-like progenitor cells
WO2014027474A1 (ja) 2012-08-17 2014-02-20 株式会社Ｃｌｉｏ 心筋梗塞の修復再生を誘導する多能性幹細胞

Also Published As

Publication number Publication date
JP5968442B2 (ja) 2016-08-10
US20150196600A1 (en) 2015-07-16
EP3659612A1 (en) 2020-06-03
WO2014027474A1 (ja) 2014-02-20
EP2886123A4 (en) 2016-06-22
US20190307806A1 (en) 2019-10-10
AU2013303492A1 (en) 2015-03-12
US9844570B2 (en) 2017-12-19
SG10201800829XA (en) 2018-03-28
ES2767182T3 (es) 2020-06-16
JPWO2014027684A1 (ja) 2016-07-28
SG11201501185WA (en) 2015-05-28
EP2886123A1 (en) 2015-06-24
PT2886123T (pt) 2020-01-22
EP3659612B1 (en) 2023-06-07
US10376544B2 (en) 2019-08-13
US20180050067A1 (en) 2018-02-22
CA2882239C (en) 2018-05-22
CN104582711A (zh) 2015-04-29
AU2013303492B2 (en) 2017-02-16
US10639335B2 (en) 2020-05-05
EP2886123B1 (en) 2019-10-23
KR101730052B1 (ko) 2017-04-25
CN104582711B (zh) 2019-12-06
PL2886123T3 (pl) 2020-05-18
DK2886123T3 (da) 2020-01-27
CA2882239A1 (en) 2014-02-20
KR20150043482A (ko) 2015-04-22
WO2014027684A1 (ja) 2014-02-20

Similar Documents

Publication Publication Date Title
IN2015DN01616A (enrdf_load_stackoverflow)
Baron et al. Mesenchymal stromal cells: a new tool against graft-versus-host disease?
Dong et al. Adipose stem cells in tissue regeneration and repair: From bench to bedside
Kim et al. Immune regulatory cells in umbilical cord blood and their potential roles in transplantation tolerance
NZ623454A (en) Pharmaceutical composition for the treatment of heart diseases
AU2009240884A8 (en) Agent for recruitment of bone-marrow-derived pluripotent stem cell into peripheral circulation
BR112014010776A8 (pt) neurônios dopaminérgicos (da) mesencefálicos para enxerto
MX340276B (es) Metodos, sistema y aparato para la deteccion, diagnostico y tratamiento de trastornos del ritmo biologico.
ES2721180T3 (es) Productos terapéuticos usando células adiposas y secreciones celulares
MX2013002381A (es) Celulas precursoras cd27 1 derivadas de medula osea para reparacion cardiaca.
BR112014012972A2 (pt) composição de meio de cultura para rejuvenscer células-tronco
Vawda et al. Current stem cell treatments for spinal cord injury
MX2015006268A (es) Diferenciacion de las celulas de fibroblastos humanos.
CA2904533C (en) Enhanced osteogenic activity of daidzein analogs on human mesenchymal stem cells
WO2014183033A3 (en) G-csf for use in treating or preventing a disease associated with aging in a patient, for administration with a stem-cell containing composition and/or an electromagnetic signal
EA201490995A1 (ru) Использование фо-ти для усиления мобилизации и пролиферации стволовых клеток
SG11201900986YA (en) Alleviation and treatment of ischemia reperfusion-induced lung injury using pluripotent stem cells
WO2014072720A3 (en) Cell differentiation
SG11201810188VA (en) Amelioration and treatment of perinatal brain damage with pluripotent stem cells
SG11201900983TA (en) Amelioration and treatment of chronic lung disease using pluripotent stem cells
WO2012169897A8 (en) Weight reducing material
WO2012050829A3 (en) Uses of il-12 and the il-12 receptor positive cell in tissue repair and regeneration
Belicchi et al. Impact of Muscular Dystrophy on the Regenerative Properties of interstitial Muscle Cells
MY203762A (en) A biological conduit for promoting recovery of an injured nerve
UA100881U (uk) Засіб для відновлення уражених тканин організму людини